Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety and tolerability of MBX-102 in
combination with allopurinol compared to allopurinol alone when administered orally once a
day for four weeks to gout patients with an inadequate hypouricemic response to allopurinol
alone.